Related Experiment Video
Updated: Aug 3, 2026
09:16
Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
Gamma-radiation-induced interactions between amino acids and glucagon
Radiation Research
|January 1, 1984
Summary
Glucagon and phenylalanine interact via the hydroxyl radical, forming larger products and adducts. Product yields vary with their molar ratio, influencing glucagon aggregation or phenylalanine polymerization.
Area of Science:
- Biochemistry
- Radiation Chemistry
Background:
- Glucagon is a key hormone regulating blood glucose.
- Phenylalanine is an essential aromatic amino acid.
- Radical-mediated reactions can modify biomolecules.
Purpose of the Study:
- To investigate the interaction between glucagon and phenylalanine induced by hydroxyl radicals.
- To determine how varying molar ratios affect product formation.
- To elucidate the mechanisms of adduct formation and the role of different radical species.
Main Methods:
- Gamma irradiation of glucagon-phenylalanine solutions.
- Analysis of reaction products using techniques to determine molecular weight and amino acid composition.
- Use of radical scavengers to probe the influence of specific radical intermediates (OH., H., e-aq).
Main Results:
- Hydroxyl radical interaction leads to higher molecular weight products, glucagon modification, and glucagon-phenylalanine adducts.
- Product distribution is dependent on the phenylalanine:glucagon molar ratio.
- Aromatic amino acids (phenylalanine, tryptophan, tyrosine) primarily form adducts via OH. radicals, while others like histidine and methionine are less specific.
Conclusions:
- The hydroxyl radical plays a significant role in modifying glucagon and phenylalanine.
- The molar ratio of reactants is critical in determining the predominant reaction pathway.
- Understanding these radical-mediated interactions is crucial for predicting biomolecular modifications in radiation environments.
Related Concept Videos
01:29Protein Folding Quality Check in the RER
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...